Partnering

INSIGHTS ON CLINICAL TRIAL PARTNERING

Automatically Triggered Micropayments And Built-In Reporting
Automated micropayments and unified trial data ease site burdens, boost participant retention, and deliver real-time insights. Discover a better way to run clinical trials.
Five Ways Centralized Trial Finance Improves Site And Patient Satisfaction
Centralizing payments and logistics improves transparency, accelerates reimbursements, and supports better site performance and patient retention in clinical trials.
3 Essential Components Of Successful Renal And Hepatic Impairment Studies
Kidney and liver function affect how drugs work in the body. Learn how impairment studies help set safe, effective dosing for these patients.
Vendor Selection Bias: Why Structured Decisions Often Fail
Learn how subtle influences derail decisions and discover proven safeguards that promote transparency, accountability, and shared ownership for better trial outcomes.

Mastering Precision Oncology Start-Up: Reducing Screening Delays
3/30/2026

Biomarker-driven trials create intricate screening hurdles. Explore creative, practical ways to accelerate start‑up, boost enrollment, and power precision oncology studies forward with greater speed.
The Hidden Cost Of Transactional Burden: It's Time For Sites To Speak Up
9/3/2025

Transactional burdens weigh heavily on sites, straining trust with sponsors and patients. See why site voices matter and how sounding off can strengthen clinical trial relationships.
Designed To Help Sites Increase Clinical Trial Capacity
7/25/2025

IQVIA One Home for Sites is a platform that serves as a neutral aggregator, connector, and communicator of the key systems and tasks a clinical research site needs to perform across all the trials it is conducting.
Central eSource: Leveraging Site Technology
2/27/2025

In this presentation, CRIO founder and co-CEO Raymond Nomizu delves into how sponsors can leverage the electronic source trend among sites through the use of Central eSource.
How Do Site Payments Impact Clinical Trial Sustainability?
4/16/2025

Financial stability is critical for trial sites, yet many sites grapple with substantial payment delays. To mitigate these challenges, it's imperative to reassess traditional payment practices,

Accelerate Drug Development With Innovative 360˚ CDMO And CRO Solutions

Accelerator™ Drug Development provides a strategic, end-to-end partnership model that helps sponsors optimize resources, overcome development challenges, and advance promising therapies.
Late Stage Customization

Learn about the benefits of a Late Stage Customization approach, including how it can support a leaner, more responsive supply chain, ensuring life-changing therapies reach patients more efficiently.
Your Partners In Drug Development And Safety

How can Ergomed use its oncology expertise, global reach, and access to patients with rare and ultra-rare diseases can help your organization achieve efficient, high-quality clinical trial execution?
Getting Biotechs GlobalReady

Our proprietary GlobalReady model covers the entire drug development journey from robust EARLY PHASE clinical foundations with ClinicReady to seamless multi-regional Late phase expansion. All managed by the one award-winning CRO, saving time and costs and delivering rigorous globally accepted data.
Drug-Drug Interaction Clinical Trials

We specialize in DDI studies, including stand-alone and 'cocktail' designs, assessing multiple CYP enzymes or transporters in single studies, from simple crossovers to complex adaptive trials.